List of Tables
Table 1. Global Chronic Kidney Disease Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Chronic Kidney Disease Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Chronic Kidney Disease Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Chronic Kidney Disease Drugs Sales (K MT) of Key Manufacturers (2020-2025)
Table 5. Global Chronic Kidney Disease Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Chronic Kidney Disease Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Chronic Kidney Disease Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Chronic Kidney Disease Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Chronic Kidney Disease Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chronic Kidney Disease Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chronic Kidney Disease Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Chronic Kidney Disease Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chronic Kidney Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chronic Kidney Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Chronic Kidney Disease Drugs Sales by Region (2020-2025) & (K MT)
Table 18. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Chronic Kidney Disease Drugs Sales by Region (2026-2031) & (K MT)
Table 20. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Chronic Kidney Disease Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Chronic Kidney Disease Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Chronic Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Chronic Kidney Disease Drugs Sales by Country (2020-2025) & (K MT)
Table 27. North America Chronic Kidney Disease Drugs Sales by Country (2026-2031) & (K MT)
Table 28. North America Chronic Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Chronic Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Chronic Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Chronic Kidney Disease Drugs Sales by Country (2020-2025) & (K MT)
Table 32. Europe Chronic Kidney Disease Drugs Sales by Country (2026-2031) & (K MT)
Table 33. Europe Chronic Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Chronic Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Chronic Kidney Disease Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2020-2025) & (K MT)
Table 37. Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2026-2031) & (K MT)
Table 38. Asia Pacific Chronic Kidney Disease Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Chronic Kidney Disease Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Chronic Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Chronic Kidney Disease Drugs Sales by Country (2020-2025) & (K MT)
Table 42. Latin America Chronic Kidney Disease Drugs Sales by Country (2026-2031) & (K MT)
Table 43. Latin America Chronic Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Chronic Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Chronic Kidney Disease Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Middle East and Africa Chronic Kidney Disease Drugs Sales by Country (2026-2031) & (K MT)
Table 48. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Chronic Kidney Disease Drugs Sales (K MT) by Type (2020-2025)
Table 51. Global Chronic Kidney Disease Drugs Sales (K MT) by Type (2026-2031)
Table 52. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Chronic Kidney Disease Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Chronic Kidney Disease Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Chronic Kidney Disease Drugs Price (USD/MT) by Type (2020-2025)
Table 59. Global Chronic Kidney Disease Drugs Price (USD/MT) by Type (2026-2031)
Table 60. Global Chronic Kidney Disease Drugs Sales (K MT) by Application (2020-2025)
Table 61. Global Chronic Kidney Disease Drugs Sales (K MT) by Application (2026-2031)
Table 62. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Chronic Kidney Disease Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Chronic Kidney Disease Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Chronic Kidney Disease Drugs Price (USD/MT) by Application (2020-2025)
Table 69. Global Chronic Kidney Disease Drugs Price (USD/MT) by Application (2026-2031)
Table 70. Keryx Biopharmaceuticals, Inc Company Information
Table 71. Keryx Biopharmaceuticals, Inc Description and Business Overview
Table 72. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product
Table 74. Keryx Biopharmaceuticals, Inc Recent Developments/Updates
Table 75. Kissei Pharmaceutical Co., Ltd Company Information
Table 76. Kissei Pharmaceutical Co., Ltd Description and Business Overview
Table 77. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product
Table 79. Kissei Pharmaceutical Co., Ltd Recent Developments/Updates
Table 80. AbbVie Company Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. AbbVie Chronic Kidney Disease Drugs Product
Table 84. AbbVie Recent Developments/Updates
Table 85. GlaxoSmithKline Company Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. GlaxoSmithKline Chronic Kidney Disease Drugs Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Sanofi Chronic Kidney Disease Drugs Product
Table 94. Sanofi Recent Developments/Updates
Table 95. F. Hoffmann-La Roche Ltd Company Information
Table 96. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 97. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product
Table 99. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Pfizer Chronic Kidney Disease Drugs Product
Table 104. Pfizer Recent Developments/Updates
Table 105. AstraZeneca Company Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. AstraZeneca Chronic Kidney Disease Drugs Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Amgen Company Information
Table 111. Amgen Description and Business Overview
Table 112. Amgen Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Amgen Chronic Kidney Disease Drugs Product
Table 114. Amgen Recent Developments/Updates
Table 115. Teva Pharmaceutical Industries Company Information
Table 116. Teva Pharmaceutical Industries Description and Business Overview
Table 117. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product
Table 119. Teva Pharmaceutical Industries Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Chronic Kidney Disease Drugs Distributors List
Table 123. Chronic Kidney Disease Drugs Customers List
Table 124. Chronic Kidney Disease Drugs Market Trends
Table 125. Chronic Kidney Disease Drugs Market Drivers
Table 126. Chronic Kidney Disease Drugs Market Challenges
Table 127. Chronic Kidney Disease Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Chronic Kidney Disease Drugs
Figure 2. Global Chronic Kidney Disease Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chronic Kidney Disease Drugs Market Share by Type: 2024 & 2031
Figure 4. ACE Inhibitors Product Picture
Figure 5. Calcium Channel Blockers Product Picture
Figure 6. Beta Blockers Product Picture
Figure 7. Others Product Picture
Figure 8. Global Chronic Kidney Disease Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Chronic Kidney Disease Drugs Market Share by Application: 2024 & 2031
Figure 10. Hospitals
Figure 11. Specialty Clinics
Figure 12. Global Chronic Kidney Disease Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Chronic Kidney Disease Drugs Market Size (2020-2031) & (US$ Million)
Figure 14. Global Chronic Kidney Disease Drugs Sales (2020-2031) & (K MT)
Figure 15. Global Chronic Kidney Disease Drugs Average Price (USD/MT) & (2020-2031)
Figure 16. Chronic Kidney Disease Drugs Report Years Considered
Figure 17. Chronic Kidney Disease Drugs Sales Share by Manufacturers in 2024
Figure 18. Global Chronic Kidney Disease Drugs Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Chronic Kidney Disease Drugs Players: Market Share by Revenue in Chronic Kidney Disease Drugs in 2024
Figure 20. Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Chronic Kidney Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Chronic Kidney Disease Drugs Sales Market Share by Country (2020-2031)
Figure 23. North America Chronic Kidney Disease Drugs Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Chronic Kidney Disease Drugs Sales Market Share by Country (2020-2031)
Figure 27. Europe Chronic Kidney Disease Drugs Revenue Market Share by Country (2020-2031)
Figure 28. Germany Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Chronic Kidney Disease Drugs Revenue Market Share by Region (2020-2031)
Figure 35. China Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Chronic Kidney Disease Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Chronic Kidney Disease Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Chronic Kidney Disease Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Chronic Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Chronic Kidney Disease Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Chronic Kidney Disease Drugs by Type (2020-2031)
Figure 57. Global Chronic Kidney Disease Drugs Price (USD/MT) by Type (2020-2031)
Figure 58. Global Sales Market Share of Chronic Kidney Disease Drugs by Application (2020-2031)
Figure 59. Global Revenue Market Share of Chronic Kidney Disease Drugs by Application (2020-2031)
Figure 60. Global Chronic Kidney Disease Drugs Price (USD/MT) by Application (2020-2031)
Figure 61. Chronic Kidney Disease Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed